40 related articles for article (PubMed ID: 17502723)
1. Health-Related Physical Fitness Evaluation in HIV-Diagnosed Children and Adolescents: A Scoping Review.
de Castro JAC; de Lima TR; Silva DAS
Int J Environ Res Public Health; 2024 Apr; 21(5):. PubMed ID: 38791753
[TBL] [Abstract][Full Text] [Related]
2. Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy.
Babu H; Ambikan AT; Gabriel EE; Svensson Akusjärvi S; Palaniappan AN; Sundaraj V; Mupanni NR; Sperk M; Cheedarla N; Sridhar R; Tripathy SP; Nowak P; Hanna LE; Neogi U
Front Immunol; 2019; 10():1965. PubMed ID: 31507593
[TBL] [Abstract][Full Text] [Related]
3. Decreased bone turnover in HIV-infected children on antiretroviral therapy.
Shiau S; Yin MT; Strehlau R; Patel F; Mbete N; Kuhn L; Coovadia A; Arpadi SM
Arch Osteoporos; 2018 Apr; 13(1):40. PubMed ID: 29623447
[TBL] [Abstract][Full Text] [Related]
4. Bone health in HIV-infected children, adolescents and young adults: a systematic review.
Arpadi SM; Shiau S; Marx-Arpadi C; Yin MT
J AIDS Clin Res; 2014 Nov; 5(11):. PubMed ID: 26504618
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men.
Ketlogetswe KS; McKibben R; Jacobson LP; Li X; Dobs AS; Budoff M; Witt MD; Palella FJ; Kingsley L; Margolick JB; Post WS; Brown TT
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):362-9. PubMed ID: 26090754
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin and DKK-1: two important regulators of bone metabolism in HIV-infected youths.
Mora S; Puzzovio M; Giacomet V; Fabiano V; Maruca K; Capelli S; Nannini P; Lombardi G; Zuccotti GV
Endocrine; 2015 Aug; 49(3):783-90. PubMed ID: 25596857
[TBL] [Abstract][Full Text] [Related]
7. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.
Kelesidis T; Currier JS; Yang OO; Brown TT
AIDS Rev; 2014; 16(3):123-33. PubMed ID: 25102334
[TBL] [Abstract][Full Text] [Related]
8. Bone health in children and adolescents with perinatal HIV infection.
Puthanakit T; Siberry GK
J Int AIDS Soc; 2013 Jun; 16(1):18575. PubMed ID: 23782476
[TBL] [Abstract][Full Text] [Related]
9. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.
Kelesidis T; Kendall MA; Yang OO; Hodis H; Currier JS
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):938-48. PubMed ID: 23351153
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations.
Cummins NW; Klicpera A; Sainski AM; Bren GD; Khosla S; Westendorf JJ; Badley AD
PLoS One; 2011; 6(9):e24876. PubMed ID: 21931863
[TBL] [Abstract][Full Text] [Related]
11. Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study.
Jang JJ; Schwarcz AI; Amaez DA; Woodward M; Olin JW; Keller MJ; Schecter AD
J Int AIDS Soc; 2010 Mar; 13():12. PubMed ID: 20307322
[TBL] [Abstract][Full Text] [Related]
12. Short-term bone loss in HIV-infected premenopausal women.
Yin MT; Lu D; Cremers S; Tien PC; Cohen MH; Shi Q; Shane E; Golub ET; Anastos K
J Acquir Immune Defic Syndr; 2010 Feb; 53(2):202-8. PubMed ID: 19890216
[TBL] [Abstract][Full Text] [Related]
13. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
Polyzos SA; Anastasilakis AD; Efstathiadou Z; Kita M; Litsas I; Avramidis A; Arsos G; Moralidis E; Gerou S; Pavlidou V; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154
[TBL] [Abstract][Full Text] [Related]
14. RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.
Rouster-Stevens KA; Langman CB; Price HE; Seshadri R; Shore RM; Abbott K; Pachman LM
Arthritis Rheum; 2007 Mar; 56(3):977-83. PubMed ID: 17328075
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
[TBL] [Abstract][Full Text] [Related]
16. [The influence of sex and age on the osteoprotegerin level in the blood].
Sobańska I; Odrowaz-Sypniewska G; Kuligowska M
Wiad Lek; 2007; 60(5-6):281-5. PubMed ID: 17966895
[TBL] [Abstract][Full Text] [Related]
17. Biology of RANK, RANKL, and osteoprotegerin.
Boyce BF; Xing L
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S1. PubMed ID: 17634140
[TBL] [Abstract][Full Text] [Related]
18. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents.
Mora S; Zamproni I; Cafarelli L; Giacomet V; Erba P; Zuccotti G; Viganò A
AIDS; 2007 May; 21(9):1129-35. PubMed ID: 17502723
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
